# Short-Term Dual Antiplatelet Therapy With Early Transi-tion to Low-dose Antiplatelet Monotherapy Using Ti-cagRelor in Chronic Coronary Artery Disease

> **NCT07080684** · PHASE4 · NOT_YET_RECRUITING · sponsor: **University of Messina** · enrollment: 1000 (estimated)

## Conditions studied

- Chronic Coronary Syndrome

## Interventions

- **DRUG:** Ticagrelor 60 mg
- **DRUG:** clopidogrel 75 mg

## Key facts

- **NCT ID:** NCT07080684
- **Lead sponsor:** University of Messina
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-01
- **Primary completion:** 2026-12
- **Final completion:** 2027-09
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2025-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07080684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07080684, "Short-Term Dual Antiplatelet Therapy With Early Transi-tion to Low-dose Antiplatelet Monotherapy Using Ti-cagRelor in Chronic Coronary Artery Disease". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07080684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*